Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett
Steven L Teitelbaum

Showing results (171-180 of 1,160) with videos related to

Pageof 116
Sort By:
Rheumatology (Oxford, England)|August 30, 2021
IgG4-related fasciitisHarriet Morf, Frank Roemer, Abbas Agaimy, et al.
Arthritis and Rheumatism|August 1, 2008
The controversial role of tumor necrosis factor alpha in fibrotic diseasesJörg H W Distler, Georg Schett, Steffen Gay, et al.
Rheumatology (Oxford, England)|July 11, 2009
Sudden visual loss in a patient with microscopic polyangiitisJochen Wacker, Rene Handschu, Bernhard Manger, et al.
Arthritis and Rheumatism|January 5, 2013
Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?Dominique Baeten, Maxime Breban, Rik Lories, et al.
Nature Reviews. Immunology|July 1, 2026
T cell engagers in autoimmune diseasesRicardo Grieshaber-Bouyer, Lei Wu, Georg Schett, et al.
Arthritis and Rheumatism|September 30, 2008
How antirheumatic drugs protect joints from damage in rheumatoid arthritisGeorg Schett, Christian Stach, Jochen Zwerina, et al.
Annals of the Rheumatic Diseases|April 15, 2010
Risk prediction for severe osteoarthritisGeorg Schett, Jochen Zwerina, Roland Axmann, et al.
European Journal of Immunology|January 27, 2012
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1Inessa Schwab, Markus Biburger, Gerhard Krönke, et al.
Plos One|August 25, 2017
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participantsLena Tschiderer, Johann Willeit, Georg Schett, et al.
Annals of the Rheumatic Diseases|April 19, 2019
Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco <i>et al</i>Johannes Knitza, Lorenzo Cavagna, Georg Schett, et al.
Pageof 116

Showing results (171-180 of 1,160) with videos related to

Sort By:
Pageof 116
Rheumatology (Oxford, England)|August 30, 2021
IgG4-related fasciitisHarriet Morf, Frank Roemer, Abbas Agaimy, et al.
Arthritis and Rheumatism|August 1, 2008
The controversial role of tumor necrosis factor alpha in fibrotic diseasesJörg H W Distler, Georg Schett, Steffen Gay, et al.
Rheumatology (Oxford, England)|July 11, 2009
Sudden visual loss in a patient with microscopic polyangiitisJochen Wacker, Rene Handschu, Bernhard Manger, et al.
Arthritis and Rheumatism|January 5, 2013
Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?Dominique Baeten, Maxime Breban, Rik Lories, et al.
Nature Reviews. Immunology|July 1, 2026
T cell engagers in autoimmune diseasesRicardo Grieshaber-Bouyer, Lei Wu, Georg Schett, et al.
Arthritis and Rheumatism|September 30, 2008
How antirheumatic drugs protect joints from damage in rheumatoid arthritisGeorg Schett, Christian Stach, Jochen Zwerina, et al.
Annals of the Rheumatic Diseases|April 15, 2010
Risk prediction for severe osteoarthritisGeorg Schett, Jochen Zwerina, Roland Axmann, et al.
European Journal of Immunology|January 27, 2012
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1Inessa Schwab, Markus Biburger, Gerhard Krönke, et al.
Plos One|August 25, 2017
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participantsLena Tschiderer, Johann Willeit, Georg Schett, et al.
Annals of the Rheumatic Diseases|April 19, 2019
Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco <i>et al</i>Johannes Knitza, Lorenzo Cavagna, Georg Schett, et al.
Pageof 116